Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CSX Corporation (CSX) vs Sanofi SA (SNY) Price & Performance

CSX CorporationTrade

Price performance (Past 24H)

Key statistics

CSX Corporation vs Sanofi SA — how do they compare? CSX Corporation trades at $50.03 (market cap $92.88B), while Sanofi SA trades at $43.25 (market cap $104.57B). The key difference: CSX Corporation and Sanofi SA are close in size by market cap, and Sanofi SA pays the higher dividend (5.56%). Which is the better fit depends on your goals.

CSXSNY
Market Cap
$92.88B$104.57B
Sector
IndustrialsHealth
52-Week High
$53.21$52.34
52-Week Low
$32.05$41.33
Enterprise Value
$110.85B$124.48B
Dividend Yield
1.12%5.56%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CSX Corporation

Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.

Read more on CSX

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY